A nonparametric Bayesian continual reassessment method in single-agent dose-finding studies
Abstract Background The main purpose of dose-finding studies in Phase I trial is to estimate maximum tolerated dose (MTD), which is the maximum test dose that can be assigned with an acceptable level of toxicity. Existing methods developed for single-agent dose-finding assume that the dose-toxicity...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2018-12-01
|
| Edice: | BMC Medical Research Methodology |
| Témata: | |
| On-line přístup: | http://link.springer.com/article/10.1186/s12874-018-0604-9 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
